Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

1979 • 279 citations

Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones

1978 • 250 citations

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

1979 • 148 citations

Experimental antitumor activity of aminoanthraquinones.

1979 • 131 citations

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

1980 • 122 citations

Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline Antibiotics

1979 • 101 citations